Covered recipient · General Payments record
SINDHU NAIR
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$2,388.43
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $262.35 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $46.59 | 2 |
| Gilead Sciences, Inc. | $43.42 | 2 |
| Astellas Pharma US Inc | $37.94 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $32.03 | 1 |
| Tempus AI, Inc | $28.49 | 1 |
| EISAI INC. | $26.34 | 1 |
| Merck Sharp & Dohme Corporation | $26.04 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $19.57 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139323944 | CMS |
| Astellas Pharma US Inc | $18.37 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139397849 | CMS |
| Daiichi Sankyo Inc. | $21.14 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089461335 | CMS |
| Daiichi Sankyo Inc. | $25.45 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089461347 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.50 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101517219 | CMS |
| Eisai Inc. | $26.34 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110781738 | CMS |
| Gilead Sciences, Inc. | $21.05 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133832632 | CMS |
| Gilead Sciences, Inc. | $22.37 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133832634 | CMS |
| Merck Sharp & Dohme LLC | $26.04 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141718402 | CMS |
| Novartis Pharmaceuticals Corporation | $32.03 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087055922 | CMS |
| Tempus AI, Inc | $28.49 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150170562 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.